Henan Taloph Pharmaceutical Stock Co.,Ltd (SHA:600222)

SHA:600222 Revenue

Henan Taloph Pharmaceutical Stock Co.,Ltd had revenue of 350.23M CNY in the quarter ending March 31, 2026, with 8.34% growth. This brings the company's revenue in the last twelve months to 1.78B, up 1.09% year-over-year. In the year 2025, Henan Taloph Pharmaceutical Stock Co.,Ltd had annual revenue of 1.76B, down -9.46%.

• Revenue (ttm): 1.78B
• Revenue Growth: +1.09%
• P/S Ratio: 2.42
• Revenue / Employee: 856.40K
• Employees: 2,084
• Market Cap: 4.32B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.76B	-183.63M	-9.46%
Dec 31, 2024	1.94B	-128.49M	-6.21%
Dec 31, 2023	2.07B	109.21M	5.57%
Dec 31, 2022	1.96B	356.18M	22.20%
Dec 31, 2021	1.60B	187.42M	13.23%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 17, 2026

Data Sources Report a data error